Article

First Total COVID-19 Antibody Test Receives Emergency Use Authorization From the FDA

Key Takeaways

  • Bio-Rad's SARS-CoV-2 Total Ab test is the first total antibody test with FDA EUA, aiding COVID-19 diagnosis.
  • The test offers over 99% diagnostic specificity and 98% sensitivity, with 100% specificity in cross-reactivity testing.
SHOW MORE

The FDA has granted Bio-Rad Laboratories Emergency Use Authorization for the company’s SARS-CoV-2 Total Ab test.

The FDA has granted Bio-Rad Laboratories Emergency Use Authorization (EUA) for the company’s severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Total Ab test. This test is the first total antibody test that has received an EUA from the FDA.1

The blood-based immunoassay test will be able to help clinicians identify whether an individual has antibodies against SARS-CoV-2, the virus associated with coronavirus disease 2019 (COVID-19). The test will be available for use both manually or on an automated immunoassay platform.1

In the clinical evaluation of the SARS-CoV-2 Total Ab test, it presented diagnostic specificity of more than 99% and diagnostic sensitivity of 98%. Furthermore, when researchers conducted cross-reactivity testing, they found the test presented specificity of 100%, with the results also presenting no reactivity against other interfering specimens, including non-CoV-2 coronaviruses.1

“The total antibody approach enables detection of antibodies in the majority of patients eight days after the onset of symptoms, versus an IgG-only approach,” said Dara Wright, MBA, Bio-Rad Clinical Diagnostics group EVP and president, in a press release. “We are pleased to have received FDA Emergency Use Authorization for our SARS-CoV-2 Total Antibody test to support COVID-19 diagnosis.”1

REFERENCE

  • Bio-Rad’s SARS-CoV-2 (COVID-19) Serology Test Granted FDA Emergency Use Authorization, the First Total Antibody Test to Receive EUA from the FDA [news release]. Hercules, CA: Bio-Rad Laboratories, Inc. April 30, 2020. businesswire.com/news/home/20200430006016/en. Accessed May 1, 2020.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com